Laura Addi

Laura Addi

Auto-generated profile, based on publicly available information

Laura Addi

National Cancer Institute Pascale Foundation, Laboratories of Mercogliano, Naples, Italy

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Small Ruminant Research
Verified
Journal Article
Closed access
RTRaffaella Tudisco
Raffaella Tudisco
MGMicaela Grossi
Micaela Grossi
SCSerena Calabrò
Serena Calabrò
Monica Isabella CutrignelliMonica Isabella Cutrignelli
Monica Isabella Cutrignelli
Nadia MuscoNadia Musco
Nadia Musco
Federico InfascelliFederico Infascelli
Federico Infascelli

1 November 2015 in Small Ruminant Research
Verified
Journal Article
Closed access
RTR. Tudisco
R. Tudisco
Biagina ChiofaloBiagina Chiofalo
Biagina Chiofalo
LAL. Addi
L. Addi
VPVittorio Lo Presti
Vittorio Lo Presti
RRR. Rao
R. Rao
Federico InfascelliFederico Infascelli
Federico Infascelli

16 December 2020 in Molecular Oncology
Verified
Journal Article
Open access
PDF file
RLRita Lombardi
Rita Lombardi
MSMaura Sonego
Maura Sonego
BPBiagio Pucci
Biagio Pucci
LALaura Addi
Laura Addi
FIFederica Iannelli
Federica Iannelli
Alfredo BudillonAlfredo Budillon
Alfredo Budillon
Acquired resistance to platinum (Pt)‐based therapies is an urgent unmet need in the management of epithelial ovarian cancer (EOC) patients. Here, we characterized by an unbiased proteomics method three isogenic EOC models of acquired Pt resistance (TOV‐112D, OVSAHO, and MDAH‐2774). Using this approach, we identified several differentially expressed proteins in Pt‐resistant (Pt‐res) compared to parental cells and the chaperone HSP90 as a central hub of these protein networks. Accordingly, up‐regulation of HSP90 was observed in all Pt‐res cells and heat‐shock protein 90 alpha isoform knockout resensitizes Pt‐res cells to cisplatin (CDDP) treatment. Moreover, pharmacological HSP90 inhibition using two different inhibitors [17‐(allylamino)‐17‐demethoxygeldanamycin (17AAG) and ganetespib] synergizes with CDDP in killing Pt‐res cells in all tested models. Mechanistically, genetic or pharmacological HSP90 inhibition plus CDDP ‐induced apoptosis and increased DNA damage, particularly in Pt‐res cells. Importantly, the antitumor activities of HSP90 inhibitors (HSP90i) were confirmed both ex vivo in primary cultures derived from Pt‐res EOC patients ascites and in vivo in a xenograft model. Collectively, our data suggest an innovative antitumor strategy, based on Pt compounds plus HSP90i, to rechallenge Pt‐res EOC patients that might warrant further clinical evaluation.

1 February 2016 in Small Ruminant Research
Verified
Journal Article
Closed access
FZF. Zicarelli
F. Zicarelli
LAL. Addi
L. Addi
RTR. Tudisco
R. Tudisco
SCS. Calabrò
S. Calabrò
PLPietro Lombardi
Pietro Lombardi
Federico InfascelliFederico Infascelli
Federico Infascelli

1 January 2015 in Italian Journal of Animal Science
Verified
Journal Article
Open access
Nadia MuscoNadia Musco
Nadia Musco
SCSerena Calabrò
Serena Calabrò
Federico InfascelliFederico Infascelli
Federico Infascelli
RTRaffaella Tudisco
Raffaella Tudisco
PLPietro Lombardi
Pietro Lombardi
Monica Isabella CutrignelliMonica Isabella Cutrignelli
Monica Isabella Cutrignelli
Seven feeds were tested in vitro using faecal inoculum from pigs. Sugar beet pulp, wheat bran, soybean hulls, grapecake, glutamic beet pulp, citrus by-product and fructo-oligosaccharides (FOS) were fermented for 96 h. Cumulative gas production was measured as indicator of the fermentation kinetics. At the end of incubation organic matter disappearance and fermentation end-products (short-chain fatty acids and NH3) were also measured. The gas production profiles were fitted with a multi-phasic model. Significant differences were detected between grapecake and FOS: the very low gas production for the first one was probably due to the high lignin and tannins contents of this by-product, while the higher organic matter cumulative gas volume (OMCV) and organic matter disappearance (OMD) values for FOS were due to the high soluble fibre proportion. Soybean hulls and citrus by-product, showed similar values of degradability and gas production and were characterised by different fermentation profiles. Grapecake s...

2 July 2016 in Italian Journal of Animal Science
Verified
Journal Article
Open access
Nadia MuscoNadia Musco
Nadia Musco
PLPietro Lombardi
Pietro Lombardi
SCSerena Calabro
Serena Calabro
VMVincenzo Mastellone
Vincenzo Mastellone
RTRaffaella Tudisco
Raffaella Tudisco
Monica Isabella CutrignelliMonica Isabella Cutrignelli
Monica Isabella Cutrignelli
The aim of the present study was to evaluate the effects of Aloe arborescens on organic matter digestibility (OMD), cumulative gas (OMCV) and short chain fatty acids (SCFA) production, using the in vitro gas production technique (IVGPT). Three adult cats were fed with a commercial diet (CP 31.21; EE 16.64% as fed) for 20 days before the collection of their faeces used as inoculum. The same diet, used as substrate, was incubated in vitro supplemented with different amounts (0, 0.7, 1.6 and 3.2%) of lyophilised Aloe arborescens. OMD, OMCV and SCFA significantly decreased with the increase of Aloe addition; an increase of l-lactic acid production was detected, even if pH was within physiological range. A potential prebiotic role of the Aloe arborescens carbohydrates was hypothesised in cats, but it needs further investigations. As a whole, our results show that IVGPT can represent a useful tool for nutritional evaluation of novel ingredient and/or additive also in cats.